Transport of gabapentin, a gamma-amino acid drug, by system l alpha-amino acid transporters: a comparative study in astrocytes, synaptosomes, and CHO cells.
The system L transporter is generally considered to be one of the major Na(+)-independent carriers for large neutral alpha-amino acids in mammalian cells. However, we found that cultured astrocytes from rat brain cortex accumulate gabapentin, a gamma-amino acid, predominately by this alpha-amino acid transport system. Uptake of gabapentin by system L transporter was also examined in synaptosomes and Chinese hamster ovary (CHO) cells. The inhibition pattern displayed by various amino acids on gabapentin uptake in astrocytes and synaptosomes corresponds closely to that observed for the system L transport activity in CHO cells. Gabapentin and leucine have Km values that equal their Ki values for inhibition of each other, suggesting that leucine and gabapentin compete for the same system L transporter. By contrast, gabapentin exhibited no effect on uptake of GABA, glutamate, and arginine, indicating that these latter three types of brain transporters do not serve for uptake of gabapentin. A comparison of computer modeling analysis of gabapentin and L-leucine structures shows that although the former is a gamma-amino acid, it can assume a conformation that can resemble the L-form of a large neutral alpha-amino acid such as L-leucine. The steady-state kinetic study in astrocytes and CHO cells indicates that the intracellular concentrations of gabapentin are about two to four times higher than that of leucine. The uptake levels of these two substrates are inversely related to their relative exodus rates. The concentrating ability by system L observed in astrocytes is consistent with the substantially high accumulation gradient of gabapentin in the brain tissue as determined by microdialysis.
Su
T Z
TZ
Department of Biotechnology, Parke-Davis Pharmaceutical Research Division, Warner Lambert Co., Ann Arbor, MI 48106, USA.
Lunney
E
E
Campbell
G
G
Oxender
D L
DL
D000085:Acetates / Q000378:metabolism*; D000588:Amines; D026905:Amino Acid Transport Systems; D000596:Amino Acids / Q000494:pharmacology; D000818:Animals; D001120:Arginine / Q000378:metabolism; D001253:Astrocytes / Q000378:metabolism*; D001667:Binding, Competitive; D001692:Biological Transport / Q000187:drug effects; D016466:CHO Cells / Q000378:metabolism*; D002352:Carrier Proteins / Q000378:metabolism*; D006224:Cricetinae; D003509:Cyclohexanecarboxylic Acids; D000077206:Gabapentin; D018698:Glutamic Acid / Q000378:metabolism; D007700:Kinetics; D007930:Leucine / Q000378:metabolism; D008297:Male; D051381:Rats; D017207:Rats, Sprague-Dawley; D013574:Synaptosomes / Q000378:metabolism*; D005680:gamma-Aminobutyric Acid / Q000378:metabolism
D000085:Acetates; D000588:Amines; D026905:Amino Acid Transport Systems; D000596:Amino Acids; D002352:Carrier Proteins; D003509:Cyclohexanecarboxylic Acids; D018698:Glutamic Acid; D005680:gamma-Aminobutyric Acid; D000077206:Gabapentin; D001120:Arginine; D007930:Leucine